Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions

Nasser Chegini, Kristina Kotseos, Barbara Bennett, Michael Peter Diamond, Lena Holmdahl, James Burns

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: To assess the presence of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP (TIMP-1) in peritoneal fluid and serum of subjects with and without adhesions. Design: Cross-sectional study. Setting: Academic research centers. Patient(s): Sixty-three patients who underwent abdominal/pelvic surgery. Intervention(s): MMP-1, TIMP-1, and MMP-1-TIMP-1 complex content. Main Outcome Measure(s): ELISA. Result(s): Peritoneal fluids (PF) and sera of subjects with and without peritoneal adhesions contain MMP-1, TIMP-1, and MMP-1-TIMP-1 complex at varying levels with 10- to 100-fold higher TIMP-1 than MMP-1. Compared with serum, PF contains a lower level of MMP-1 in subjects with mild adhesions and without adhesions, higher TIMP-1 in subjects with extensive adhesions, and lower MMP-1-TIMP-1 complex in subjects with moderate adhesions. However, the serum and PF content of MMP-1, TIMP-1, and MMP-1-TIMP-1 complex was not statistically different among subjects with or without adhesions, with the exception of TIMP-1 in PF of subjects with extensive adhesions. MMP1-TIMP-1 ratio indicates that a major portion of MMP-1 is in complex with TIMP-1. There was no age- or gender-dependent difference in MMP-1 and TIMP-1 content in serum or PF. Conclusion(s): Despite differences in MMP-1 and TIMP-1 levels in serum and PF of subjects with extensive and moderate adhesions, there is no correlation between MMP-1 and TIMP-1, with the exception of higher TIMP-1 in PF of subjects with extensive adhesions.

Original languageEnglish (US)
Pages (from-to)1207-1211
Number of pages5
JournalFertility and sterility
Volume76
Issue number6
DOIs
StatePublished - Dec 17 2001

Fingerprint

Matrix Metalloproteinase 1
Tissue Inhibitor of Metalloproteinase-1
Matrix Metalloproteinase Inhibitors
Ascitic Fluid
Matrix Metalloproteinases
Serum

Keywords

  • MMP-1
  • Peritoneal adhesion
  • Peritoneal fluid
  • TIMP-1 serum

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions. / Chegini, Nasser; Kotseos, Kristina; Bennett, Barbara; Diamond, Michael Peter; Holmdahl, Lena; Burns, James.

In: Fertility and sterility, Vol. 76, No. 6, 17.12.2001, p. 1207-1211.

Research output: Contribution to journalArticle

Chegini, Nasser ; Kotseos, Kristina ; Bennett, Barbara ; Diamond, Michael Peter ; Holmdahl, Lena ; Burns, James. / Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions. In: Fertility and sterility. 2001 ; Vol. 76, No. 6. pp. 1207-1211.
@article{dbc6944cdeb24c9c9ea740270905547d,
title = "Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions",
abstract = "Objective: To assess the presence of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP (TIMP-1) in peritoneal fluid and serum of subjects with and without adhesions. Design: Cross-sectional study. Setting: Academic research centers. Patient(s): Sixty-three patients who underwent abdominal/pelvic surgery. Intervention(s): MMP-1, TIMP-1, and MMP-1-TIMP-1 complex content. Main Outcome Measure(s): ELISA. Result(s): Peritoneal fluids (PF) and sera of subjects with and without peritoneal adhesions contain MMP-1, TIMP-1, and MMP-1-TIMP-1 complex at varying levels with 10- to 100-fold higher TIMP-1 than MMP-1. Compared with serum, PF contains a lower level of MMP-1 in subjects with mild adhesions and without adhesions, higher TIMP-1 in subjects with extensive adhesions, and lower MMP-1-TIMP-1 complex in subjects with moderate adhesions. However, the serum and PF content of MMP-1, TIMP-1, and MMP-1-TIMP-1 complex was not statistically different among subjects with or without adhesions, with the exception of TIMP-1 in PF of subjects with extensive adhesions. MMP1-TIMP-1 ratio indicates that a major portion of MMP-1 is in complex with TIMP-1. There was no age- or gender-dependent difference in MMP-1 and TIMP-1 content in serum or PF. Conclusion(s): Despite differences in MMP-1 and TIMP-1 levels in serum and PF of subjects with extensive and moderate adhesions, there is no correlation between MMP-1 and TIMP-1, with the exception of higher TIMP-1 in PF of subjects with extensive adhesions.",
keywords = "MMP-1, Peritoneal adhesion, Peritoneal fluid, TIMP-1 serum",
author = "Nasser Chegini and Kristina Kotseos and Barbara Bennett and Diamond, {Michael Peter} and Lena Holmdahl and James Burns",
year = "2001",
month = "12",
day = "17",
doi = "10.1016/S0015-0282(01)02874-6",
language = "English (US)",
volume = "76",
pages = "1207--1211",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions

AU - Chegini, Nasser

AU - Kotseos, Kristina

AU - Bennett, Barbara

AU - Diamond, Michael Peter

AU - Holmdahl, Lena

AU - Burns, James

PY - 2001/12/17

Y1 - 2001/12/17

N2 - Objective: To assess the presence of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP (TIMP-1) in peritoneal fluid and serum of subjects with and without adhesions. Design: Cross-sectional study. Setting: Academic research centers. Patient(s): Sixty-three patients who underwent abdominal/pelvic surgery. Intervention(s): MMP-1, TIMP-1, and MMP-1-TIMP-1 complex content. Main Outcome Measure(s): ELISA. Result(s): Peritoneal fluids (PF) and sera of subjects with and without peritoneal adhesions contain MMP-1, TIMP-1, and MMP-1-TIMP-1 complex at varying levels with 10- to 100-fold higher TIMP-1 than MMP-1. Compared with serum, PF contains a lower level of MMP-1 in subjects with mild adhesions and without adhesions, higher TIMP-1 in subjects with extensive adhesions, and lower MMP-1-TIMP-1 complex in subjects with moderate adhesions. However, the serum and PF content of MMP-1, TIMP-1, and MMP-1-TIMP-1 complex was not statistically different among subjects with or without adhesions, with the exception of TIMP-1 in PF of subjects with extensive adhesions. MMP1-TIMP-1 ratio indicates that a major portion of MMP-1 is in complex with TIMP-1. There was no age- or gender-dependent difference in MMP-1 and TIMP-1 content in serum or PF. Conclusion(s): Despite differences in MMP-1 and TIMP-1 levels in serum and PF of subjects with extensive and moderate adhesions, there is no correlation between MMP-1 and TIMP-1, with the exception of higher TIMP-1 in PF of subjects with extensive adhesions.

AB - Objective: To assess the presence of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP (TIMP-1) in peritoneal fluid and serum of subjects with and without adhesions. Design: Cross-sectional study. Setting: Academic research centers. Patient(s): Sixty-three patients who underwent abdominal/pelvic surgery. Intervention(s): MMP-1, TIMP-1, and MMP-1-TIMP-1 complex content. Main Outcome Measure(s): ELISA. Result(s): Peritoneal fluids (PF) and sera of subjects with and without peritoneal adhesions contain MMP-1, TIMP-1, and MMP-1-TIMP-1 complex at varying levels with 10- to 100-fold higher TIMP-1 than MMP-1. Compared with serum, PF contains a lower level of MMP-1 in subjects with mild adhesions and without adhesions, higher TIMP-1 in subjects with extensive adhesions, and lower MMP-1-TIMP-1 complex in subjects with moderate adhesions. However, the serum and PF content of MMP-1, TIMP-1, and MMP-1-TIMP-1 complex was not statistically different among subjects with or without adhesions, with the exception of TIMP-1 in PF of subjects with extensive adhesions. MMP1-TIMP-1 ratio indicates that a major portion of MMP-1 is in complex with TIMP-1. There was no age- or gender-dependent difference in MMP-1 and TIMP-1 content in serum or PF. Conclusion(s): Despite differences in MMP-1 and TIMP-1 levels in serum and PF of subjects with extensive and moderate adhesions, there is no correlation between MMP-1 and TIMP-1, with the exception of higher TIMP-1 in PF of subjects with extensive adhesions.

KW - MMP-1

KW - Peritoneal adhesion

KW - Peritoneal fluid

KW - TIMP-1 serum

UR - http://www.scopus.com/inward/record.url?scp=0035199612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035199612&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(01)02874-6

DO - 10.1016/S0015-0282(01)02874-6

M3 - Article

C2 - 11730752

AN - SCOPUS:0035199612

VL - 76

SP - 1207

EP - 1211

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -